CM101, a novel monoclonal antibody targeting CCL24, in patients with primary sclerosing cholangitis: results from spring study

nebokitug intravenous (CM-101 intravenous) - ChemomAb

https://gut.bmj.com/content/74/Suppl_1/A22.2

Douglas Thorburn 1; Stephen T Barclay 2; Deepak Joshi 3; Palak Trivedi 4; Mathew Cramp 5; Chenchu Ramu Chimakurthi 6; George Mells 7; Emma Culver 8; Matt Frankel 9; John Lawler 9; Adi Mor 9

Jun 19, 2025